[Vasodilator treatment in pulmonary hypertension].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D009573:Nitrites / Q000627:therapeutic use; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D009573:Nitrites; D011465:Prostaglandins, Synthetic; D014665:Vasodilator Agents
Tratamentul cu vasodilatatoare în hipertensiunea pulmonară.